非转移性乳腺癌的辅助性内分泌治疗策略:一个网络的元分析

Andri Papakonstantinou1,2, Guillermo Villacampa3,4, Victor Navarro4

  • 1Oncology/Pathology Department, Karolinska Institutet, Stockholm, Sweden.

EClinicalMedicine
|March 4, 2025
PubMed
概括

早期乳腺癌的最佳内分泌疗法因更年期状态而异. 卵巢功能抑制加上芳酶抑制剂对更年期前妇女是最好的,而芳酶抑制剂或切换疗法对更年期后妇女有益,改善无疾病生存率.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...